Embeda (im-BED-a) is a new oral opioid designed to limit abuse

October 2009

Embeda (im-BED-a) is a new oral opioid designed to limit abuse.

But don't be lulled into a false sense of security.

The capsules contain extended-release morphine pellets with an inner core of the opioid antagonist naltrexone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Influenza using antivirals and vaccines for the current flu season
computer alert about possible serotonin syndrome when patients get more than one serotonergic drug
Respiratory & Allergy new OTC cough and cold syrup called Clofera (chlophedianol/pseudoephedrine)
Cardiology whether a DOUBLE dose of clopidogrel (Plavix) improves outcomes in cardiac patients
Diabetes questions about how to switch between insulins
Women's Health You'll hear more about limiting antidepressants during pregnancy
Women's Health whether Yaz and Yasmin (drospirenone/ethinyl estradiol) are riskier than other combined oral contraceptives
Statins questions about resolving statin myopathy
Neurology & Pain Embeda (im-BED-a) is a new oral opioid designed to limit abuse
Psychiatry Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder
Ophthalmology Claritin Eye and Zyrtec Itchy Eye Drops don't contain the active ingredient that you'd expect